PowerPoint 프레젠테이션

Similar documents
내시경 conference

조기 위암 집담회 부산대학교 병원 CASE

Very low-risk Low-risk Intermediate-risk High-risk Appendiceal mucinous tumours Mucinous adenoma Mucinou

Jkbcs042.hwp

연하곤란

untitled

Kjhps016( ).hwp

(49-54)Kjhps004.hwp

김범수

1장

Stated as T1 [NOS] or T1c [NOS] with no other information on tumor size Described as "less than 3 cm," or "greater than 2 cm," or "between

388 The Korean Journal of Hepatology : Vol. 6. No COMMENT 1. (dysplastic nodule) (adenomatous hyperplasia, AH), (macroregenerative nodule, MR

슬라이드 1

Kjtcs324( ).hwp

PowerPoint 프레젠테이션

<B0E6C8F1B4EBB3BBB0FA20C0D3BBF3B0ADC1C E687770>

Minimally invasive parathyroidectomy

황지웅

Thieme: Color Atlas of Acupuncture

ePapyrus PDF Document

Jkbcs016(92-97).hwp

슬라이드 1

2012 년도암등록실무자교육 암등록과질병분류의차이 ( 수 ) 홍성옥

120304강신용

KJOG Vol. 55, No. 11, 2012 Fig. 1. Positron emission tomography image; Hypermetabolic huge mass in the pelvic cavity, suggesting malignancy (arrow). A

슬라이드 1

Jkbcs032.hwp

센티미터 (cm) 로표현된종양크기는반올림하지않는다. [ 예 1] 6.5mm 크기의유방암 code 007 [ 예 2] 2.3mm 크기의폴립내암종 code 002 [ 예 3] 암의병소크기가 0.5mm code 001 종양크기를사용하지않는스키마에대한코드 : Code Desc

qc course lecture #1

Kaes017.hwp

The Korean Journal of Pathology 2005; 39: 위암병리보고서기재사항표준화 김우호 박철근 김영배 김윤화김호근 배한익 송규상 장희경장희진 채양석 대한병리학회소화기병리학연구회 A Standardized Pathology Report

P.P.TEMPLATE KOREA

이상협, 김현열 liver and lung metastasis of breast-acc on positron emission tomography (PET) scans. Breast-ACC is needed a tailored treatment Key words: bre

슬라이드 1

Microsoft PowerPoint - 발표자료(KSSiS 2016)

CS LYMPH NODES 설명 이필드에서는진단시침습된국소림프절을확인한다. 침습의기준은부위별로다르며침습된 국소림프절의위치, 편측성, 크기, 개수등을포함한다. 일반적으로침습된원격림프절은 CS Mets at Dx 에서코딩한다. Code Description TNM7 TNM

( )Jkstro011.hwp

암등록지침 변경및주요사항공지 (2014) 년암등록자료삭제항목 년암등록자료추가항목 3. 암등록지침변경사항 4. 기타공지사항 암등록지침서 정오표 6. 부록

The Clinicopathologic Characteristics of Cases with Negative Pathologic Diagnosis after Endoscopic Submucosal Dissection

슬라이드 1

ca

untitled

Korean J Otorhinolaryngol-Head Neck Surg 2016;59(3):233-7 Fig. 1. Representative imaging of right metastatic lymphadenopathy in cancer of unknown prim

슬라이드 1

지원연구분야 ( 코드 ) LC0202 과제번호 창의과제프로그램공개가능여부과제성격 ( 기초, 응용, 개발 ) 응용실용화대상여부실용화공개 ( 공개, 비공개 ) ( 국문 ) 연구과제명 과제책임자 세부과제 ( 영문 ) 구분 소속위암연구과직위책임연구원

ÀÇÇа�ÁÂc00Ì»óÀÏ˘

2-1

Trd022.hwp


Hyo Sun Kim, et al. 증례 /100 mmhg, 82 /, 20 /, 36.0 C, (Murphy s sign). 4,890/mm 3, 12.8 g/dl, 378,000/mm 3, 7.08 mg/dl, 5.54 mg/dl, AST 5

한약치료와표적항암요법 ( 아피니토 ) 을병행하여부분관해된신세포암간전이환자 1 례 Abstract Sung-Hwan Chang 1, Ji-Hye Park 1,2, Hwa Seung Yoo,2*

( )Jksc057.hwp

Jung YH, et al. 228 증 례 진전은 없었다. 검사 소견: 말초혈액검사나 혈청 생화학검사는 정상이었고, 갑상 환자: 55세, 여자 선기능검사는 갑상선자극호르몬(thyroid stimulating hormone) 1.68 주소: 갑상선 우연종 µiu/ml (

Jksvs019(8-15).hwp

Case Report Korean J Otorhinolaryngol-Head Neck Surg 2018;61(1):47-51 / pissn / eissn

<C1A63530C8B820BCBCB9CCB3AA2DC6EDC1FD2E687770>

Radiologic Evaluation of Prostate Cancer

New code and term

STKP.PDF

노영남

The Korean Journal of Pathology 2006; 40: 대장암병리보고서기재사항표준화 장희진 박철근 김우호 김영배김윤화 김호근 배한익 송규상장미수 장희경 채양석 대한병리학회소화기병리학연구회 A Standardized Pathology R


KISEP Case Reports Korean J Otolaryngol 1998;41 9 : 두경부영역에발생한횡문근육종 4 례 하승룡 이봉재 박선태 김상윤 Four Cases of Rhabdomyosarcoma in the Head and Neck Se

Annual report of cancer statistics in Korea in

< B3E220C6F3BECFBAB4B1E2C1B6BBE720C0DAB7E1B1B8C1B62E687770>

<C1A63535C8B820BCBCB9CCB3AA2DC6EDC1FD2E687770>

Site-Specific Factor 2 - Clinical Assessment of Regional Lymph Nodes (Colon, Appendix, Rectum) 자료원 : 영상보고서, 이용가능한신체검사지 ( 외과적관찰또는림프절조직검사는포함하지않는다.) 이필드의

<31312EB9DABCB1BFB52E687770>

기관고유연구사업결과보고

암센터뉴스레터1

KISEP Head and Neck Korean J Otolaryngol 2001;44:190-5 두경부암종에서병리학적으로확인한 Level IIb 림프절전이 - 예비결과 - 고윤우 1 김동영 2 최재진 1 김인섭 1 김상엽 1 최은창 1 Pathologically Pr

<30352EB0A3BAB4B8AE2E687770>

전립선암발생률추정과관련요인분석 : The Korean Cancer Prevention Study-II (KCPS-II)

위장관 종양에서 F-18 FDG PET/PET-CT의 이용 29 A C B Fig. 1. Poorly differentiated adenocarcinoma with signet ring cell component reveals poor FDG uptake. A. Sha

KISEP Otology Korean J Otolaryngol 2005;48: 외이도편평상피암종의치료경험 연세대학교의과대학이비인후과학교실, 1 한림대학교의과대학이비인후과학교실, 2 이화여자대학교의과대학이비인후과학교실 3 정상호 1 김창우 2 김한수 3 이원상

°ûÁø¿µ

歯Can025.PDF

Investment Proposal

6. ÀÇÇа�ÁÂc00åÇ×¼®Â39~250

untitled

슬라이드 1

EsophagusGEJunctionschma.hwp

À̱ٿµ

( ) Jkra076.hwp

Intest Res 2013;11(1):14-22 나, 과거에는비교적드문질환이고병에대한정확한이해가부족하여명확하게분류되지못했다 년세계보건기구 (World Health Organizati

Sok Kyun Hong, et al : A case of carcinoid tumor of ampulla of vater presenting as asthmatic symptoms :, 57 : : kg. :, 1998 l. :. :, 110/70 mmh

untitled

슬라이드 1

<3034C0D3BBF3C3E1B0E8C7D0BCFABCBCB9CCB3AA2E687770>

untitled

untitled

현재도 피운다. (a) Half pack a day (b) half to one pack a day 반 갑 미만 반 갑 ~ 한 갑 (c) one to two packs a day (d) more than 2 packs a day 한 갑 ~ 두 갑 두 갑 이상 5. Ho

목 차 Ⅰ. 개요 Ⅱ. 위암적정성평가세부추진계획 Ⅲ. 간암진료결과평가세부추진계획 2

untitled

Transcription:

SEER Summary Staging 이현경

병기란? - 환자개개인의질병의확장정도에 따라특정하게분류하는방법 - 의학분야종사자들이서로다른암에 관한정보를교환하기위해공통의언 어로개발

병기의목적 환자의치료결정 예후암시 생존율의추정치제공 치료결과비교

병기의종류 TNM : 거의모든 site에사용 FIGO : 여성의 reproductive site cancers의 staging Clark s Level : Melanoma staging Dukes : Colon과 Rectum의 staging Ann Arbor : 림프종에대한 staging 기타 : Breslow s, National Wilms s Tumor study Group 등

Summary Staging - 암이원발부위로부터얼마나멀리퍼져있는지를범주화해놓은가장기초적인방법 - General staging, California staging SEER staging - NCI 의 SEER 프로그램에의해개발 - 임파종과백혈병을포함모든해부학적부위에적용 - TNM 정보와상응하는요약병기코드기록가능

3. Summary Staging 의구조 Code Definition 0 In situ 1 Localized only 2 Regional by direct extension only 3 Regional lymph nodes involved only 4 Regional by BOTH direct extension AND lymph node involvement 5 Regional, NOS 7 Distant site(s)/node(s) involved 9 Unknown if extension or metastasis (unstaged, unknown, or unspecified Death certification only case)

In situ (code = 0) in place 를의미 조직의기저막 (basement membrane) 이나기질 (stroma) 를침입하지않음. Carcinoma, Melanoma 만이상피내암종으로분류가능 침윤 (Invasion), 림프절전이, 원격전이의증거가있는경우엔상피내암종이아님

In situ (code = 0)

In situ (code = 0) ** 동의어 non-invasive, pre-invasive, non-infiltrating, intraepithelial, Stage 0, intraductal, intracystic, no stromal invasion, no penetration, below the basement membrane ** 주의 In situ with microinvasion 라고기록된경우 Localized (1)

Localized (code = 1) Basement membrane 을침윤하였으나 confined to organ of origin 상태 원발장기를벗어나지않고, 장기내에넓게퍼지거나전이하는경우

Localized (code = 1)

Localized (code = 1) lamina propria, myometrium, muscularis 원발부위내의혈관침범, perineural lymphatic invasion 다른장기로전이의증거가없어야

Regional (code = 2~5) 원발장기의경계를벗어난종양확장 병기가 In situ, local, distant 가아닌경우 (carcinoma) 4가지의세부범주를가진다. 1) 주변으로 extension된경우 (code=2) 2) 림프절에종양포함된경우 (code=3) 3) 1) 과 2) 가모두해당되는경우 (code=4) 4) regional, NOS (code=5)

Regional (code = 2~5)

Regional (code = 2~5) ** 주의 전이된림프절중가장먼림프절을생각한다. TNM과다른타병기분류에서림프절포함이라면, 림프절전이를고려하여병기를분류한다. 의무기록내용과 TNM 병기에모순이있다면, 의무기록에우선하고, 의사와상의한다. 전이된림프절이메뉴얼상 regional로언급되지않았다면, 원격전이로추정한다.

Distant (code = 7) = remote, diffuse, disseminated, metastasis, secondary disease 원발부위에서떨어져서, 신체의다른 장기로이동하고, 새로운장소에서 자라기시작

Distant (code = 7) 전이방법 원발부위와인접한조직을넘어선전이 초기림프절을넘어서다른림프절로의전이 혈액성혹은혈액운반전이 신체공동속의유동액을통한전이 (implantation, seeding mets)

Distant (code = 7)

Distant (code = 7)

Distant (code = 7)

Distant (code = 7) ** 원격전이가주로일어나는부위 간, 폐, 뇌, 뼈 ** 특별히명명되지않은조직이나림프절은우선원격전이로의심 ** 항상 distant인경우 Hematopoietic 질환 ** 주의 Plasmacytoma, Histiocytosis 중일부

Unknown if extension or metastasis (code = 9) C80.9 = code 9 병기분류에필요한충분한증거가 없을때 : 검사전사망, 진단이나치료 거부, 환자나이나금기로인한검사 제한 가능한한이코드를분류하기않기위해 더많은정보를찾도록해야한다. Death certificate only case

General Guidelines 임상, 수술 / 조직평가를모두검토하여분류 수술후혹은진단후 4개월이내의정보를포함하여분류 진단확정후에일어난전이는병기분류시제외 수술 / 조직정보가임상정보와반증한다면, 수술 / 조직정보우선

General Guidelines 특정부위에관한지침은일반지침보다우선한다. carcinoma와 melanoma는우선 in situ를확인한다. In situ, Distant, Localized, Regional 순으로확인하여분류한다. 만약원격전이가언급되어졌다면 Code는 (7번:distant) 를준다.

1. Serosa 2. Tela subserosa 3. Muscularis 4. Oblique fibers of muscle wall 5. Circular muscle layer 6. Longitudinal muscle layer 7. Submucosa 8. Lamina muscularis Mucosae 9. Mucosa 10. Lamina propria 11. Epithelium 12. Gastric glands 13. Gastric pits 14. Villous folds 15. Gastric areas (gastric surface) Layers of Stomach

Mucosa, NOS Muscle(muscularis) Submucosa Lamina propria, Stroma, Subepitelial connective tissue, Tunica propria, Subserosa TNM/AJCC T, T2 원발부위별요약병기코딩규칙 Bladder 0 In situ carcinoma in situ, NOS Noninvasive papillary(transitional) cell carcinoma papillary non-infiltrating papillary transitional cell carcinoma, stated to be noninvasive 1. Localized only

원발부위별요약병기코딩규칙 Bladder 2 Regional By direct extension only Extension to: Adventitia, Peritoneum, periureteral fat/tissue, prostate Serosa, Ureter, Seminal vesicle 3. Regional by lymph node(s) involved only Lymph nodes(iliac, pelvic, perivesicla, sacral ) 4. Regional by BOTH direct extension AND regional lymph node(s) involved codes (2) + (3)

원발부위별요약병기코딩규칙 Bladder 7. Distant site(s)/lymph node(s) involved Distant lymph node(s): common iliac, Other distant lymph nodes Extension to: Abdoninal wall, bone, colon, pelvic wall, rectum Further contiguous extension Metastasis 9. Unknown if extension or metastasis

원발부위별요약병기코딩규칙 Bladder ( 예제 ) - 62 세남환, 1 년전건강검진에서 hematuria 있었으나치료없이지내던중 10 일전부터 gross hematuria 있어서외부병원에서 work up - IVP(Intravenous pyelography), ultrasono 시행후 bladder ca 진단하에 2000.11.10 외래진료후 op 위해 admission - IVP : upper tract normal - Bladder sono : right lateral wall 에 2cm size mass - OP : bladder, tumor, right lateral wall transurethral resection : papillary transitional cell carcinoma, grade I/III with no stromal invasion

원발부위별요약병기코딩규칙 - key word 1) papillary transitional cell carcinoma, 2) no stromal invasion 요약병기 : 0

원발부위별요약병기코딩규칙 Breast 0 In situ Noninvasive; intraepithelial Intraductal without infiltration ** M8500/2 Intraductal carcinoma, noninfiltrating, NOS M8500/3 Infiltrating duct carcinoma, NOS 1. Localized only Confined to breast tissue and fat including nipple and/or areola Paget disease WITH or WITHOUT underlying tumor

원발부위별요약병기코딩규칙 Breast 2 Regional By direct extension only - Attachment of fixation to pectoral muscle of underlying tissue - Extensive skin involvement En cuirasse, Erythema, Inflammation of skin, Peaud orange Skin edema, Ulceration of skin of breast - Invasion of (or fixation of) Chest wall, Intercostal muscle, Rib, subcutaneous tissue 3. Regional by lymph node(s) involved only Lymph nodes(axillary, Infraclavicular )

원발부위별요약병기코딩규칙 Breast 4. Regional by BOTH direct extension AND regional lymph node(s) involved codes (2) + (3) 7. Distant site(s)/lymph node(s) involved Distant lymph node(s): Cervical, Contralateral/bilateral axillary vein, supraclavicular Further contiguous extension Skin over (Axilla, Contralateral breast, sternum, upper abdomen) Metastasis

원발부위별요약병기코딩규칙 Breast( 예제 ) - Infiltrating duct carcinoma - Breast, right, modified radical mastectomy - Key word Lymph node : metastasis in 5 out of 14 axillary lymph nodes - Pathology - 요약병기 : 3

원발부위별요약병기코딩규칙 Liver 0 In situ Noninvasive;intraepithelial 1. Localized only Confined to one lobe with or without vascular invasion Multiple(satelite)nodules/tumors confined to one lobe Confined to liver, NOS 2 Regional By direct extension only More than one lobe involved by contiguous growth

원발부위별요약병기코딩규칙 Ovary 0. Noninvasive, intraepithelial, Preinvasive 1. Localized only FIGO stage IA, IB, I 2. Regional by direct extension only FIGO stage IIB, IIC,II 7. Distant site(s)/lymph node(s) involved FIGO stage IIIA, IIIB, IIIC,III, IV

원발부위별요약병기코딩규칙 Ovary ( 예제 ) - clear cell carcinoma - oophorectomy, salpingectomy - Key word stage : T1a, (FIGO IA) 17 lymph node with no tumor involvement - Pathology- 요약병기 : 1

Hodgkin and non-hodgkin Lymphoma of all sites

원발부위별요약병기코딩규칙 Hodgkin and non-hodgkin Lymphoma of all sites 1. Localized - nodal lymphoma 하나의 Lymph node involve 된경우 (I) - extranodal lymphoma 하나의기관의일부분에국한되어 involve 된경우 (II) 하나의기관에여러부분이 involve 된경우 (II) - spleen 에만 involve 된경우 (IS)

1. Localized N Ex-N S 장기 횡격막 Spleen 임파절 I IE IS

원발부위별요약병기코딩규칙 Hodgkin and non-hodgkin Lymphoma of all sites 5. Regional, NOS - nodal lymphoma 횡격막을기준으로한쪽부분에있는 lymph node 가둘이상 involve 된경우 (II) - extranodal lymphoma 근접기관이나조직으로 extension(iie) 하나의기관과 regional lymph node, 또는횡격막을기준으로기관과같은부분의 lymph node 들이 involve 된경우 - Spleen 관련 spleen 과횡격막아래에있는하나의기관이 invole 된경우 (with/without 횡격막아래부분 lymph node 의 involve)(iies) spleen 과횡격막아래부분에있는 lymph node 가 involve (IIS)

5. Regional N Ex-N S 장기 횡격막 장기 Spleen 장기 IIEs 임파절 IIs II IIE II

원발부위별요약병기코딩규칙 Hodgkin and non-hodgkin Lymphoma of all sites 7. Distant - Nodal lymphoma 횡격막을기준으로양쪽부분 lymph node 에 involve(iii) - extranodal lymphoma 하나의기관과횡격막기준으로다른쪽부분에있는 lymph node 들이 involve 된경우 (IIIE) - spleen 관련 spleen 과횡격막윗부분에있는 lymph node, 그리고 Extralymphatic 기관이 involve 된경우 (IIIES) spleen 과횡격막윗부분의 extralymphatic 기관, 그리고 lymph node 가 involve 된경우 (IIIES)

7. Distant N Ex-N S 횡격막 Spleen 임파절 장기 III IIIE IIIs

7. Distant Ex-N Ex-N 장기 횡격막 Spleen 장기 Spleen 장기 장기 IIIEs IIIEs IV

원발부위별요약병기코딩규칙 Hodgkin and non-hodgkin Lymphoma of all sites 7. Distant - 하나이상의 extralymphatic 기관에 disseminate 된경우 (IV) - 둘이상의 extralymphatic 기관이 involve 된경우 (IV) - metastases(bone marrow, Liver)

7. Distant 횡격막 Dissemin ation Metastasis (bone marrow Liver)

예제풀이여행예제풀이여행

Lung 예제 풀이 - 41 세남환, cough, sputum, rhinorrhea - Chest CT A nodule on LUL, sugesting cancer Left Pl thickening with invasion to visceral pleura - Bone scan : Degenerative lesion in L3-4 & L5-S1 - PET CT Lobulated with increased FDG uptake in Left lung apex several protruding lesions in lateral and posterial wall of the bladder, probable bladder diverticula - LUL lobectomy and mediastinal dissection - Path : Adenosquamous carcinoma, 3.7x 2.8cm vascular invasion : present, Pleural invasion : present bronchial margin : clear, lymphatic invasion : present lymph node metastasis in six out of 45 reginoal lymph node

Lung 예제 풀이 - Key word invasion to visceral pleura ( chest CT ) Pleura invasion : present ( path ) lymph node metastases in six out of 45 regional lymph node ( path ) 요약병기 : 4

Pancreas 예제 풀이 - 59 세남, abdominal pain - CT : pancreatic mass at proximal tail, pancreatic ductal dilation - ERCP(endoscopic retrograde cholangiopancreatography) Bile duct : not remarkable Pancreatic duct : pancreatic cancer, tail - Path soft tissue named pericolon tissue : free from tumor soft tissue named pancreas tumor : Fibrotic wall without lining epithelium showing chroic inflamation pancreas : Adenocarcinoma, poorly differentiated lymphovascula permeation, hypovascula permeation Lymph node : regional(1/10) metastatic carcinoma

Pancreas 예제 풀이 - Key word Lymph node : regional(1/10) metastatic carcinoma (Path) 요약병기 : 3

예제 풀이 Rectum 56 세, 여성 : melena - CT : Irregular wall thickening involving lower rectum with small regional L/Ns - Colonoscopy : No definite evidence of distant metastasis - OP : Large bowel anterior resection - Path : Adenocarcinoma, moderately differentiated 4.5cm x 3.5cm Extent of invasion : perirectal adipose tissue venous invasion : not identified angiolymphatic invasion : not identified Lymph nodes: no metastasis in 18 lymph node

예제 풀이 Rectum - Key word extent of invasion : perirectal adipose tissue lymph node : no metastasis in 18 lymph node - Pathology - 요약병기 : 2

예제 풀이 Ovary - 35 세여성, Lower abdomen mass - CEA/CA-125 6.6/211.9 - Pelvis CT Huge pelvic and lower abdominal mass with solid and cystic component ovarian cancer most likely. Ascites and seeding to mesenteric root, omentum and peritoneum. - Chest CT Hematogenous lung metastasis without interval change. - Kidney sono Bilateral hydronephorosis 가있으며이중 right side 가좀더심한 hydronephorosis 를보임

예제 풀이 Ovary Key word - seeding to mesenteric root, omentum and peritoneum.(pelvis CT) - Hematogenous lung metastasis without interval change.(chest CT) 요약병기 : 7

예제 풀이 Lymphoma - 64 세여성, 1 week of swelling, left neck, - Chest CT : Lobular right superior mediastinal mass consistent with clinical diagnosis of hodgkins lymphoma in paratracheal node - Bone scan : negative - Liver scan : Within normal limit - OP : staging laparotomy and splenectomy - Path : L cervical node biopsy : Hodgikin lymphoma, mixed cellularity Bone marrow : negative Spleen : Hodgikin lymphoma, mixed cellularity

예제 풀이 Ovary Key word - Paratracheal node (above diaphragm-ct) - Cervical lymph node (above diaphragm-path) - Spleen involved (below diaphragm-path) 요약병기 : 7

Collaborative Stage 현재주로사용되는 stage는 TNM stage와 Summary stage(1977, 2000) 각각의체계가다르고호환성이부족 세가지병기시스템의분류방식을모두만족시키는단일화된자료수집시스템으로개발 모든암종의병기분류시스템호환가능

Collaborative Staging

Collaborative staging(cs) Task Force Team American Joint Committee on Cancer National Cancer Registrars Association National Program of Cancer Registries, Centers for Disease control and prevention Statistics Canada American Joint on Cancer Surveillance, Epidemiology, and End Results Program, National cancer Institute North American Association of Central Cancer Registries

2.40.40 2011 Dec- current

일반적지침 2004년 1월 1일이후에진단받은환자에게적용 모든암이대상 ( 현미경적확진여부와관계없음 ) 현미경적으로확진되지않은경우임상의사가원발부위라고생각하는부위의체계에맞춰코드를줘야함 Staging 하는시기는 TNM, Summary staging이모두같음 ( 첫번째단계로진행된수술치료나진단이후 4개월안에수집된모든정보가기초- 병이진행되지않은경우 ) 진단후진행된전이자료는 staging시배제

일반적지침 항목별코드는일반적으로높은번호가종양이더많이진행된것을나타내도록되어있음. 각항목별로가능한가장높은번호를부여할것 코딩시임상적, 병리적정보를모두사용 CS Tumor Size, CS Extension, CS Lymph Nodes, CS Mets at Dx 항목은임상적그리고수술 / 병리적으로얻어진자료를모두종합하여가장멀리진행된상태를기록 모든암조직이절제되지않은경우수술시 Gross observation은중요한정보. 조직병리결과와수술기록이차이가있을경우병리조직결과에근거하여코딩할것

일반적지침 환자가수술전에항암치료, 방사선치료, 호르몬치료등의치료를받지않았는데수술 / 병리정보와임상정보에차이가있을경우병리정보를우선으로할것 만일수술전에치료를한경우임상정보에의존하여코딩할것. 임상정보 ( 피부의진행양상묘사, 원발부위크기, 원격림프절전이등은 stage를바꿀수있으므로주의깊게살펴볼것 ) 수술전치료를받았을경우에는임상, 수술 / 병리를종합하여가장진행이많이된경우의정보를사용하여코딩. 특정부위나조직병리진단에한정되는지침은일반적지침에우선.

일반적지침 부검에서얻은정보는병리결과에서얻어진정보와같은방법으로사용됨 사망진단서만가지고코딩을하는경우는 9, 99, 888등 ( 모름, 해당없음 ) 에해당하는코드를사용 Regional lymph nodes positive나 Regional lymph nodes examined는병리결과에근거해야함

Collaborative Staging Item ITEM Description CS Tumor Size 종양의크기 ( 구체적크기명시 ) CS Extension 종양이퍼진정도 CS TS/Ext Eval CS 크기와퍼진정도의확정방법 CS Lymph nodes 임파선관여여부 ( 관여된종류, 범위 ) Regional Nodes Positive 양성반응결과나온임파선개수 Regional Nodes Exam 총검사한임파선개수 CS Reg Nodes Eval 임파선진단관련사항확정방법 CS Mets at Dx Mets 여부 ( 어느부위전이 ) CS Mets at Dx-Bone CS Mets at Dx-Brain CS Mets at Dx-Liver CS Mets at Dx-Lung CS <Mets Eval Mets 진단확정방법

Collaborative Staging Item ITEM CS Site-spec Factors 1-25 Lymph-Vascular Invasion Grade Path Value Grade Path System Description 암종별로 specific 한요소 25항목 Lymph-vascular Invasion 여부 2, 3, 4 grade system일경우 ( 분자 or 첫번째숫자 ) 2,3,4 grade system일경우 ( 분모 or 두번째숫자r) Examples Final pathologic diagnosis listed as grade 1/4. Code Grade Path System as 4. Microscopic description reports high grade III of III. Code Grade Path System as 3.

Tumor Size Examples Mammogram shows 2.5 cm breast malignancy 025 CT of chest shows 4 cm mass in RUL 040 Prostate TURP shows 0.6 mm carcinoma 001

CS Extension

CS Tumor SIZE/EXT Eval

CS Mets at Dx

CS Mets at Dx-Bone

Lymph-vascular invasion

Grade path value

http://www.cancerstaging.org/cstage/manuals/index.html

Testomatic program (CS version 02.02 사용 )

감사합니다 감사합니다